pocketful logo
Bombay Oxygen Investments Ltd logo

Bombay Oxygen Investments Ltd

NSE: BSE: 509470

20152

(0.95%)

Sat, 28 Feb 2026, 00:36 am

Bombay Oxygen Investments Analysis

dividend

thumbs up icon

Pros

    thumbs up icon

    Cons

    • Bombay Oxygen Investments is not paying a notable dividend for India, therefore no need to check if the payments are increasing.
    • No need to calculate the sustainability of Bombay Oxygen Investments's dividends as it is not paying a notable one for India.
    • Bombay Oxygen Investments is not paying a notable dividend for India, therefore no need to check if the payments are stable.
    • Bombay Oxygen Investments's pays a lower dividend yield than the bottom 25% of dividend payers in India (0.76%).
    • Bombay Oxygen Investments's dividend is below the markets top 25% of dividend payers in India (3.08%).

    health

    thumbs up icon

    Pros

    • Bombay Oxygen Investments is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
    • Bombay Oxygen Investments is profitable, therefore cash runway is not a concern.
    • Bombay Oxygen Investments is profitable, therefore cash runway is not a concern.
    • Bombay Oxygen Investments has no debt, it does not need to be covered by operating cash flow.
    • Bombay Oxygen Investments has no debt, it does not need to be covered by short term assets.
    • Bombay Oxygen Investments's cash and other short term assets cover its long term commitments.
    • Bombay Oxygen Investments currently has no debt however we can't compare to 5 years ago as we have no data for that period.
    • Bombay Oxygen Investments has no debt, therefore coverage of interest payments is not a concern.
    • Bombay Oxygen Investments has no debt.
    • Low level of unsold assets.
    thumbs up icon

    Cons

      management

      thumbs up icon

      Pros

      • Hema's remuneration is lower than average for companies of similar size in India.
      • Hema's compensation has been consistent with company performance over the past year, both up more than 20%.
      • The average tenure for the Bombay Oxygen Investments management team is over 5 years, this suggests they are a seasoned and experienced team.
      thumbs up icon

      Cons

      • The average tenure for the Bombay Oxygen Investments board of directors is less than 3 years, this suggests a new board.

      misc

      thumbs up icon

      Pros

        thumbs up icon

        Cons

        • Bombay Oxygen Investments is not covered by any analysts.

        past

        thumbs up icon

        Pros

        • Bombay Oxygen Investments's 1-year earnings growth exceeds its 5-year average (228.4% vs 12.8%)
        • Bombay Oxygen Investments's year on year earnings growth rate has been positive over the past 5 years.
        • Bombay Oxygen Investments's earnings growth has exceeded the IN Chemicals industry average in the past year (228.4% vs 9.1%).
        thumbs up icon

        Cons

        • Bombay Oxygen Investments used its assets less efficiently than the IN Chemicals industry average last year based on Return on Assets.
        • It is difficult to establish if Bombay Oxygen Investments improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.
        • Bombay Oxygen Investments has not efficiently used shareholders’ funds last year (Return on Equity less than 20%).

        value

        thumbs up icon

        Pros

        • Bombay Oxygen Investments is good value based on assets compared to the IN Chemicals industry average.
        thumbs up icon

        Cons

        • Bombay Oxygen Investments's share price is above the future cash flow value, it's not available at a moderate discount (< 20%).
        • Bombay Oxygen Investments's share price is above the future cash flow value, it's not available at a substantial discount (< 40%).
        • Bombay Oxygen Investments is overvalued based on earnings compared to the IN Chemicals industry average.
        • Bombay Oxygen Investments is overvalued based on earnings compared to the India market.
        • BSE:509470 is up 5.8% underperforming the Chemicals industry which returned 6.9% over the past month.
        • BSE:509470 is up 5.8% underperforming the market in India which returned 8% over the past month.

        Open Your Free Demat Account Now!

        Step into a world of zero fees and limitless opportunities!

        pocketful logo

        2022-25 Pocketful. All rights reserved, Built with in India

        Version -5.76

        app image 1app image 2

        Explore

        Calculatorsfooter arrow down icon
        Popular Calculatorsfooter arrow down icon
        Group Stocksfooter arrow down icon

        Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800